Genistein Attenuates Nonalcoholic Steatohepatitis and Increases Hepatic PPAR γ in a Rat Model

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Susutlertpanya, Warinda ^a   Werawatganon, Duangporn ^a   Siriviriyakul, Prasong ^a   Klaikeaw, Naruemon ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

GENISTEIN; MALONALDEHYDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG MECHANISM; ENZYME INDUCTION; HISTOPATHOLOGY; LIVER LEVEL; LIVER PROTECTION; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT MODEL; TREATMENT OUTCOME;

EID: 84938150132     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/509057     Document Type: Article

References (32)

1. T. Pacana and A. J. Sanyal, "Recent advances in understanding/management of non-alcoholic steatohepatitis, " F1000Prime Reports, vol. 7, article, 2015.
2. K. Y. Jung, S. Y. Cho, H. J. Kim, S. B. Kim, and I. H. Song, "Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology, " Journal of Clinical Gastroenterology, vol. 48, no. 10, pp. 883-888, 2014.
3. D. R. LaBrecque, Z. Abbas, F. Anania et al., "World gastroenterology organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, " Journal of Clinical Gastroenterology, vol. 48, no. 6, pp. 467-473, 2014.
4. A. Kadayifci, R. B. Merriman, and N. M. Bass, "Medical treatment of non-alcoholic steatohepatitis, " Clinics in Liver Disease, vol. 11, no. 1, pp. 119-140, 2007.
5. K. L. Houseknecht, B. M. Cole, and P. J. Steele, "Peroxisome proliferator-activated receptor gamma (PPAR) and its ligands: a review, " Domestic Animal Endocrinology, vol. 22, no. 1, pp. 1-23, 2002.
6. M. Inoue, T. Ohtake, W.Motomura et al., "Increased expression of PPAR in high fat diet-induced liver steatosis in mice, " Biochemical and Biophysical Research Communications, vol. 336, no. 1, pp. 215-222, 2005.
7. C.-Y. Zhao, L.-L. Jiang, L. Li, Z.-J. Deng, B.-L. Liang, and J.-M. Li, "Peroxisome proliferator activated receptor-gamma in pathogenesis of experimental fatty liver disease, " World Journal of Gastroenterology, vol. 10, no. 9, pp. 1329-1332, 2004.
8. T. Akiyama, J. Ishida, S. Nakagawa et al., "Genistein, a specific inhibitor of tyrosine-specific protein kinases, " The Journal of Biological Chemistry, vol. 262, no. 12, pp. 5592-5595, 1987.
9. M. B. Ruiz-Larrea, A. R. Mohan, G. Paganga, N. J. Miller, G. P. Bolwell, and C. A. Rice-Evans, "Antioxidant activity of phytoestrogenic isoflavones, " Free Radical Research, vol. 26, no. 1, pp. 63-70, 1997.
10. M. Hämälaïnen, R. Nieminen, P. Vuorela, M. Heinonen, and E. Moilanen, "Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-B activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-B activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages, " Mediators of Inflammation, vol. 2007, Article ID 45673, 10 pages, 2007.
11. A. L. Salas, T. D. Montezuma, G. G. Fariña, J. Reyes-Esparza, and L. Rodŕ?guez-Fragoso, "Genistein modifies liver fibrosis and improves liver function by inducing uPA expression and proteolytic activity in CCl4-treated rats, " Pharmacology, vol. 81, no. 1, pp. 41-49, 2008.
12. M. Yalniz, I. H. Bahcecioglu, N. Kuzu et al., "Preventive role of genistein in an experimental non-alcoholic steatohepatitis model, " Journal of Gastroenterology and Hepatology, vol. 22, no. 11, pp. 2009-2014, 2007.
13. G. Ji, Q. Yang, J. Hao et al., "Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms, " International Immunopharmacology, vol. 11, no. 6, pp. 762-768, 2011.
14. M. G. Busby, A. R. Jeffcoat, L. T. Bloedon et al., "Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men, " American Journal of Clinical Nutrition, vol. 75, no. 1, pp. 126-136, 2002.
15. E. M. Brunt, C. G. Janney, A. M. Di Bisceglie, B. A. Neuschwander-Tetri, and B. R. Bacon, "Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions, " The American Journal of Gastroenterology, vol. 94, no. 9, pp. 2467-2474, 1999.
16. C. P. Day and O. F. W. James, "Steatohepatitis: a tale of two 'Hits'?" Gastroenterology, vol. 114, no. 4, pp. 842-845, 1998.
17. C. P. Day, "Pathogenesis of steatohepatitis, " Bailliere's Best Practice and Research in Clinical Gastroenterology, vol. 16, no. 5, pp. 663-678, 2002.
18. H. Esterbauer, R. J. Schaur, and H. Zollner, "Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes, " Free Radical Biology and Medicine, vol. 11, no. 1, pp. 81-128, 1991.
19. M. Koruk, S. Taysi, M. C. Savas, O. Yilmaz, F. Akcay, and M. Karakok, "Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis, " Annals of Clinical & Laboratory Science, vol. 34, no. 1, pp. 57-62, 2004.
20. A. Arora, M. G. Nair, and G. M. Strasburg, "Antioxidant activities of isoflavones and their biological metabolites in a liposomal system, " Archives of Biochemistry and Biophysics, vol. 356, no. 2, pp. 133-141, 1998.
21. J. Zielonka, J.G?bicki, and G.Grynkiewicz, "Radical scavenging properties of genistein, " Free Radical Biology and Medicine, vol. 35, no. 8, pp. 958-965, 2003.
22. S.Mohamed Salih, P. Nallasamy, P. Muniyandi, V. Periyasami, andA.CaraniVenkatraman, "Genistein improves liver function and attenuates non-alcoholic fatty liver disease in a ratmodel of insulin resistance, " Journal of diabetes, vol. 1, no. 4, pp. 278-287, 2009.
23. F. Pérez-Aguilar, S. Benlloch, M. Berenguer, B. Beltrán, and J. Berenguer, "Non-alcoholic steatohepatitis: physiopathological, clinical and therapeutic implications, " Revista Española de Enfermedades Digestivas, vol. 96, no. 9, pp. 628-648, 2004.
24. J. Crespo, A. Cayoen, P. Fernendez-Gil et al., "Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients, " Hepatology, vol. 34, no. 6, pp. 1158-1163, 2001.
25. H. Dong, F.-E. Lu, Z.-Q. Gao, L.-J. Xu, K.-F. Wang, and X. Zou, "Effects of emodin on treating murine nonalcoholic fatty liver induced by high caloric laboratory chaw, " World Journal of Gastroenterology, vol. 11, no. 9, pp. 1339-1344, 2005.
26. J.-S. Zhao, F.-S. Zhu, S. Liu, C.-Q. Yang, and X.-M. Chen, "Pioglitazone ameliorates nonalcoholic steatohepatitis by downregulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats, " ChineseMedical Journal, vol. 125, no. 13, pp. 2316-2321, 2012.
27. J. Ye, "Regulation of PPAR function by TNF-, " Biochemical and Biophysical Research Communications, vol. 374, no. 3, pp. 405-408, 2008.
28. A. Bitto, D. Altavilla, A. Bonaiuto et al., "Effects of aglycone Genistein in a rat experimental model of postmenopausal metabolic syndrome, "TheJournal of Endocrinology, vol. 200, no. 3, pp. 367-376, 2009.
29. Z.-C. Dang, V. Audinot, S. E. Papapoulos, J. A. Boutin, and C. W. G. M. Löwik, "Peroxisome proliferator-activated receptor gamma (PPARgamma) as amolecular target for the soy phytoestrogen genistein, " The Journal of Biological Chemistry, vol. 278, no. 2, pp. 962-967, 2003.
30. O. Mezei, W. J. Banz, R. W. Steger, M. R. Peluso, T. A. Winters, and N. Shay, "Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW264.7 cells, " The Journal of Nutrition, vol. 133, no. 5, pp. 1238-1243, 2003.
31. C. W. Wu, E. S. H. Chu, C. N. Y. Lam et al., "PPAR is essential for protection against nonalcoholic steatohepatitis, " GeneTherapy, vol. 17, no. 6, pp. 790-798, 2010.
32. Y.-M.Nan, F.Han, L.-B. Kong et al., "Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice, " Scandinavian Journal ofGastroenterology, vol. 46, no. 3, pp. 358-369, 2011.